← Eichor
Condition: Primary Prevention Cvd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Primary Prevention Cvd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Methods of T Cell Depletion Trial (MoTD)
Phase 2 · 17 location(s) · University of Birmingham · NCT04888741Stroke Prevention in Nigeria 2 Trial
Phase 4 · 2 location(s) · Vanderbilt University Medical Center · NCT06526117Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NA · 14 location(s) · Fundación Instituto de Estudios de Ciencias de la Salud de C · NCT03711110Blood Pressure Following Isometric Exercise in Inactive Adults
NA · 1 location(s) · Canterbury Christ Church University · NCT06937164Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-7
Phase 4 · 1 location(s) · Yonsei University · NCT03770312Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years
NA · 19 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05373940A Hospital-Based Registry of Preventive Cardiology Clinics
Phase N/A · 1 location(s) · National Institute of Cardiovascular Diseases, Pakistan · NCT06503341Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Ident
Phase N/A · 1 location(s) · E.S.stroes · NCT06995183Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
Phase 3 · 2 location(s) · Hospital Moinhos de Vento · NCT05155137Cardiometabolic Risk Factors Registry
Phase N/A · 1 location(s) · Austral University, Argentina · NCT04040777Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4 · 4 location(s) · Silesian Centre for Heart Diseases · NCT05465031Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Hear
NA · 35 location(s) · Boston Scientific Corporation · NCT07069738Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial (CV
NA · 17 location(s) · IRCCS Policlinico S. Donato · NCT06832644Health Warnings and Counseling for Smoking Cessation
NA · 1 location(s) · Hitotsubashi University · NCT07098065Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema
Phase 3 · 32 location(s) · Pharvaris Netherlands B.V. · NCT07266805Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy i
Phase 4 · 1 location(s) · Saint Vincent's Hospital, Korea · NCT06186037Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support T
NA · 1 location(s) · China National Center for Cardiovascular Diseases · NCT07400549Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PRE
Phase 4 · 17 location(s) · Instituto de Investigación Marqués de Valdecilla · NCT07611747Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients
NA · 1 location(s) · Saint Vincent's Hospital, Korea · NCT07045623Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
Phase 2 · 7 location(s) · Nyrada Pty Ltd · NCT07362446Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in
Phase 3 · 62 location(s) · Pharvaris Netherlands B.V. · NCT06679881Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENT
Phase 4 · 61 location(s) · Seoul National University Hospital · NCT05845489Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05504928A Clinical Study on Exercise Guided by CPET to Reduce the Risk of Metabolic Cardiovascular Diseases（C-MET Trial）
NA · 1 location(s) · Peking University Third Hospital · NCT06528639Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients
Phase 2 · 1 location(s) · University Medical Centre Ljubljana · NCT07245069ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Phase 4 · 32 location(s) · Jung-min Ahn · NCT06676280A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi Arabia
Phase N/A · 1 location(s) · Takeda · NCT07263685China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-C
Phase 4 · 20 location(s) · Shenzhen Ausa Pharmed Co.,Ltd · NCT04974138China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
Phase 4 · 20 location(s) · Shenzhen Ausa Pharmed Co.,Ltd · NCT04974151GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification
Phase 4 · 1 location(s) · Asan Medical Center · NCT06722521
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.